Corrigendum: Natural Killer Cells From Patients With Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of Cd56bright Nkg2a+++ Cells, and yet Display Increased Degranulation and Higher Perforin Content [Front Immunol, 8, (2017), (798)] Doi: 10.3389/Fimmu.2017.00798

Corrigendum: Natural Killer Cells From Patients With Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of Cd56bright Nkg2a+++ Cells, and yet Display Increased Degranulation and Higher Perforin Content [Front Immunol, 8, (2017), (798)] Doi: 10.3389/Fimmu.2017.00798 Publisher

Dobbs K¹ ; Tabellini G² ; Calzoni E³ ; Patrizi O² ; Martinez P⁴ ; Giliani SC³ ; Moratto D³ ; Alherz W⁵ ; Cancrini C^{6, 7} ; Cowan M⁸ ; Bleesing J⁹ ; Booth C¹⁰ ; Buchbinder D¹¹ ; Burns SO^{10, 12} Show All Authors

Dobbs K¹
Tabellini G²
Calzoni E³
Patrizi O²
Martinez P⁴
Giliani SC³
Moratto D³
Alherz W⁵
Cancrini C^{6, 7}
Cowan M⁸
Bleesing J⁹
Booth C¹⁰
Buchbinder D¹¹
Burns SO^{10, 12}
Chatila TA¹³
Chou J¹³
Dazacajigal V¹⁰
De Bruin LMO¹³
De La Morena MT¹⁴
Di Matteo G^{6, 7}
Finocchi A^{6, 7}
Geha R¹³
Goyal RK¹⁵
Hayward A¹⁶
Holland S¹⁷
Huang CH¹⁸
Kanariou MG¹⁹
King A²⁰
Kaplan B²¹
Kleva A²¹
Kuijpers TW²²
Lee BW¹⁸
Lougaris V²³
Massaad M¹³
Meyts I²⁴
Morsheimer M²⁵
Neven B²⁶
Pai SY²⁷
Parvaneh N^{28, 29}
Plebani A²³
Prockop S³⁰
Reisli I³¹
Soh JY¹⁸
Somech R³²
Torgerson TR³³
Kim YJ³⁴
Walter JE³⁵
Gennery AR^{36, 37}
Keles S³¹
Manis JP³⁸
Marcenaro E³⁹
Moretta A³⁹
Parolini S²
Notarangelo LD¹

Show Affiliations

1. Laboratory of Host Defenses, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States
2. Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy
3. 'A. Nocivelli Institute for Molecular Medicine', Pediatric Clinic, University of Brescia, Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, Brescia, Italy
4. Hospital de Ninos Ricardo Gutierrez, Buenos Aires, Argentina
5. Department of Pediatrics, Faculty of Medicine, Kuwait University, Kuwait City, Kuwait
6. DPUO, Division of Immuno-Infectivology, University Department of Pediatrics, Bambino Gesu Children's Hospital, Rome, Italy
7. School of Medicine, University of Tor Vergata, Rome, Italy
8. Pediatric Allergy Immunology and Blood and Marrow Transplant Division, University of California, San Francisco, BenioffChildren's Hospital, San Francisco, CA, United States
9. Division of Hematology/Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States
10. Institute for Immunity and Transplantation, University College London, London, United Kingdom
11. Division of Pediatric Hematology, Children's Hospital Orange County, University of California Irvine, Orange County, CA, United States
12. Department of Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom
13. Division of Immunology, Boston Children's Hospital, Boston, MA, United States
14. Division of Allergy and Immunology, Southwestern Medical Center, University of Texas, Dallas, TX, United States
15. Division of Hematology/Oncology/BMT, Children's Mercy Hospital and Clinics, Kansas City, MO, United States
16. Department of Pediatrics, Brown University, Providence, RI, United States
17. Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States
18. Department of Paediatrics, National University Hospital, Singapore
19. Department of Immunology-Histocompatibility, 'Aghia Sophia' Children's Hospital, Athens, Greece
20. Division of Pediatric Immunology, Hospital Luis Calvo Mackenna, Santiago, Chile
21. Department of Pediatrics, Division of Allergy and Immunology, Hofstra Northwell School of Medicine, Hofstra University, Great Neck, NY, United States
22. Department of Pediatric Hematology, Immunology and Infectious Diseases, Emma Children's Hospital, Academic Medical Center (AMC), University of Amsterdam, Amsterdam, Netherlands
23. Department of Experimental and Clinical Sciences, University of Brescia, Brescia, Italy
24. Department of Pediatrics, University Hospitals Leuven, Leuven, Belgium
25. Transplantation Branch, Division of Allergy, Immunology and Transplantation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, United States
26. Pediatric Hematology-Immunology Department, Hospital Necker-Enfants Malades, Institute Imagine, AP-HP, Paris Descartes University, Sorbonne-Paris-Cite, Paris, France
27. Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA, United States
28. Division of Allergy and Clinical Immunology, Department of Pediatrics, Tehran University of Medical Sciences, Tehran, Iran
29. Research Center for Immunodeficiencies, Children's Medical Center, Tehran, Iran
30. Bone Marrow Transplant Service, Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, United States
31. Division of Pediatric Immunology and Allergy, Meram Medical Faculty, Necmettin Erbakan University, Konya, Turkey
32. Pediatric Immunology Unit, The Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
33. Department of Pediatrics and Immunology, Seattle Children's Hospital, University of Washington, Seattle, WA, United States
34. Division of Infectious Diseases and Immunodeficiency, Department of Pediatrics, Samsung Medical Center, School of Medicine, Sungkyunkwan University, Seoul, South Korea
35. Division of Pediatric Allergy/Immunology, University of South Florida at Johns Hopkins All Children's Hospital, St. Petersburg, FL, United States
36. Department of Paediatric Immunology, Great North Children's Hospital, Newcastle Upon Tyne, United Kingdom
37. Institute of Cellular Medicine, Newcastle University, Newcastle Upon Tyne, United Kingdom
38. Department of Laboratory Medicine, Boston Children's Hospital, Boston, MA, United States
39. Molecular Immunology Laboratories, Department of Experimental Medicine, University of Genoa, Genoa, Italy

Source: Frontiers in Immunology Published:2017

Abstract

There was a mistake in the authorship. The name of Nima Parvaneh was unintentionally omitted. Dr. Parvaneh has contributed biological specimens and clinical and immunological data from patient P66 included in the manuscript, and as such he should be included in the authorship. The authors apologize for the mistake. This error does not change the scientific conclusions of the article in any way. With the inclusion of Dr. Parvaneh's name in the authorship, the paragraph of Author Contributions should also be corrected as follows: JM, EM, AM, SP, and LN designed the study, interpreted the data, and wrote the manuscript; KD, GT, EC, OP, PM, SG, and DM performed experiments, acquired and analyzed the data; WA-H, CC, MC, JB, CB, DB, SB, TC, JC, VD-C, LOdB, MTdlM, GM, AF, RG, RKG, AH, SH, C-HH, MK, AlKi, BK, AnKl, TK, BL, VL, MiMa, IM, MeMo, BN, S-YP, NP, AP, SP, IR, JS, RS, TT, Y-JK, JW, AG, and SK contributed patient samples and clinical and immunological data; all authors have revised the work for its intellectual content, have approved its final version and have agreed to be accountable for all aspects related to the accuracy and integrity of the work. This correction does not change the scientific conclusions of the article in any way. Author apologizes for these errors and thank you for your consideration. The original has been updated. © 2017 Dobbs and et al.

Style	Citing Format
MLA	Dobbs K, et al.. "Corrigendum: Natural Killer Cells From Patients With Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of Cd56bright Nkg2a+++ Cells, and yet Display Increased Degranulation and Higher Perforin Content [Front Immunol, 8, (2017), (798)] Doi: 10.3389/Fimmu.2017.00798." Frontiers in Immunology, vol. 8, no. OCT, 2017, pp. -.
APA	Dobbs K, Tabellini G, Calzoni E, Patrizi O, Martinez P, Giliani SC, Moratto D, Alherz W, Cancrini C, Cowan M, Bleesing J, Booth C, Buchbinder D, Burns SO, Chatila TA, Chou J, Dazacajigal V, De Bruin LMO, De La Morena MT, ... Notarangelo LD (2017). Corrigendum: Natural Killer Cells From Patients With Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of Cd56bright Nkg2a+++ Cells, and yet Display Increased Degranulation and Higher Perforin Content [Front Immunol, 8, (2017), (798)] Doi: 10.3389/Fimmu.2017.00798. Frontiers in Immunology, 8(OCT), -.
Chicago	Dobbs K, Tabellini G, Calzoni E, Patrizi O, Martinez P, Giliani SC, Moratto D, et al.. "Corrigendum: Natural Killer Cells From Patients With Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of Cd56bright Nkg2a+++ Cells, and yet Display Increased Degranulation and Higher Perforin Content [Front Immunol, 8, (2017), (798)] Doi: 10.3389/Fimmu.2017.00798." Frontiers in Immunology 8, no. OCT (2017): -.
Harvard	Dobbs K et al. (2017) 'Corrigendum: Natural Killer Cells From Patients With Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of Cd56bright Nkg2a+++ Cells, and yet Display Increased Degranulation and Higher Perforin Content [Front Immunol, 8, (2017), (798)] Doi: 10.3389/Fimmu.2017.00798', Frontiers in Immunology, 8(OCT), pp. -.
Vancouver	Dobbs K, Tabellini G, Calzoni E, Patrizi O, Martinez P, Giliani SC, et al.. Corrigendum: Natural Killer Cells From Patients With Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of Cd56bright Nkg2a+++ Cells, and yet Display Increased Degranulation and Higher Perforin Content [Front Immunol, 8, (2017), (798)] Doi: 10.3389/Fimmu.2017.00798. Frontiers in Immunology. 2017;8(OCT):-.
BibTex	@article{ author = {Dobbs K and Tabellini G and Calzoni E and Patrizi O and Martinez P and Giliani SC and Moratto D and Alherz W and Cancrini C and Cowan M and Bleesing J and Booth C and Buchbinder D and Burns SO and Chatila TA and Chou J and Dazacajigal V and De Bruin LMO and De La Morena MT and Di Matteo G and Finocchi A and Geha R and Goyal RK and Hayward A and Holland S and Huang CH and Kanariou MG and King A and Kaplan B and Kleva A and Kuijpers TW and Lee BW and Lougaris V and Massaad M and Meyts I and Morsheimer M and Neven B and Pai SY and Parvaneh N and Plebani A and Prockop S and Reisli I and Soh JY and Somech R and Torgerson TR and Kim YJ and Walter JE and Gennery AR and Keles S and Manis JP and Marcenaro E and Moretta A and Parolini S and Notarangelo LD}, title = {Corrigendum: Natural Killer Cells From Patients With Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of Cd56bright Nkg2a+++ Cells, and yet Display Increased Degranulation and Higher Perforin Content [Front Immunol, 8, (2017), (798)] Doi: 10.3389/Fimmu.2017.00798}, journal = {Frontiers in Immunology}, volume = {8}, number = {OCT}, pages = {-}, year = {2017} }
RIS	TY - JOUR AU - Dobbs K AU - Tabellini G AU - Calzoni E AU - Patrizi O AU - Martinez P AU - Giliani SC AU - Moratto D AU - Alherz W AU - Cancrini C AU - Cowan M AU - Bleesing J AU - Booth C AU - Buchbinder D AU - Burns SO AU - Chatila TA AU - Chou J AU - Dazacajigal V AU - De Bruin LMO AU - De La Morena MT AU - Di Matteo G AU - Finocchi A AU - Geha R AU - Goyal RK AU - Hayward A AU - Holland S AU - Huang CH AU - Kanariou MG AU - King A AU - Kaplan B AU - Kleva A AU - Kuijpers TW AU - Lee BW AU - Lougaris V AU - Massaad M AU - Meyts I AU - Morsheimer M AU - Neven B AU - Pai SY AU - Parvaneh N AU - Plebani A AU - Prockop S AU - Reisli I AU - Soh JY AU - Somech R AU - Torgerson TR AU - Kim YJ AU - Walter JE AU - Gennery AR AU - Keles S AU - Manis JP AU - Marcenaro E AU - Moretta A AU - Parolini S AU - Notarangelo LD TI - Corrigendum: Natural Killer Cells From Patients With Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of Cd56bright Nkg2a+++ Cells, and yet Display Increased Degranulation and Higher Perforin Content [Front Immunol, 8, (2017), (798)] Doi: 10.3389/Fimmu.2017.00798 JO - Frontiers in Immunology VL - 8 IS - OCT SP - EP - PY - 2017 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract